Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Pak, Jaewoo ^a   Chang, Jae Jin ^b   Lee, Jung Hun ^a,c   Lee, Sang Hee ^c  

^a Stems Medical Clinic   (South Korea)

^b Oriental Bio Group   (South Korea)

^c Myong Ji University   (South Korea)

Author keywords

Adipose tissue derived stem cells; Complications; Mesenchymal stem cell; Orthopedics; Platelet rich plasma; Safety

Indexed keywords

ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED STEM CELL; ADULT; AGED; ANKLE; ARTICLE; BACK; BRAIN HEMORRHAGE; CARCINOGENESIS; FEMALE; FOLLOW UP; HIP; HUMAN; INFECTION; JOINT; KNEE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATIENT SAFETY; STEM CELL; SWELLING; TENDINITIS; THROMBOCYTE RICH PLASMA; VISUAL ANALOG SCALE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; JOINT DISEASES; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; PATIENT SAFETY; PLATELET-RICH PLASMA; QUESTIONNAIRES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TELEPHONE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888391674     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-337     Document Type: Article

References (46)

1. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Ando W, Tateishi K, Hart DA, Katakai D, Tanaka Y, Nakata K, Hashimoto J, Fujie H, Shino K, Yoshikawa H, Nakamura N, Biomaterials 2007 28 5462 5470 10.1016/j.biomaterials.2007.08.030 17854887 (Pubitemid 47599635)
2. In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties, and further chondrogenic potential. Ando W, Tateishi K, Katakai D, Hart DA, Hiquchi C, Nakata K, Hashimoto J, Fujie H, Shino K, Yoshikawa H, Nakamura N, Tissue Eng Part A 2008 14 2041 2049 10.1089/ten.tea.2008.0015 18636944
3. Phenotypic plasticity of human articular chondrocytes. Tallheden T, Dennis JE, Lennon DP, Sjoqren-Jansson E, Caplan AI, Lindahl A, J Bone Joint Surg Am 2003 85-A Suppl 93 100 12721350 (Pubitemid 36535050)
4. The manipulated mesenchymal stem cells in regenerated skeletal tissues. Nevo Z, Robinson D, Horowitz S, Hasharoni A, Yayon A, Cell Transplant 1998 7 63 70 10.1016/S0963-6897(97)00066-3 9489764 (Pubitemid 28082324)
5. The role of mesenchymal stem cells in maintenance and repair of bone. Bielby R, Jones E, McGonagle D, Injury 2007 38 Suppl 26 32
6. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM, J Bone Joint Surg Am 1994 76 579 592 8150826 (Pubitemid 24154130)
7. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Nishimura K, Nakai T, Ando K, Hotta T, Biomaterials 2003 24 3531 3541 10.1016/S0142-9612(03)00222-9 12809782 (Pubitemid 36703127)
8. Autologous mesenchymal progenitor cells in articular cartilage repair. Johnstone B, Yoo JU, Clin Orthop Relat Res 1999 367 Suppl 156 162
9. Mobilization of bone marrow derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K, Knee Surg Sports Traumatol Arthrosc 2006 14 1307 1314 10.1007/s00167-006-0124-8 16788809 (Pubitemid 44800660)
10. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T, Spine 2005 30 2379 2387 10.1097/01.brs.0000184365.28481.e3 16261113 (Pubitemid 41567599)
11. Meniscus regeneration in a rabbit partial meniscectomy model. Walsh CJ, Goodman D, Caplan AI, Goldberg VM, Tissue Eng 1999 5 327 337 10.1089/ten.1999.5.327 10477855 (Pubitemid 29398712)
12. Repair of chronic osteochondral defects in the rat. A bone marrow-stimulating procedure enhanced by cultured allogenic bone marrow mesenchymal stromal cells. Nishimori M, Deie M, Kanaya A, Exham H, Adachi N, Ochi M, J Bone Joint Surg Br 2006 88 1236 1244 16943480
13. Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow. Yamasaki T, Deie M, Shinomiya R, Izuta Y, Yasunaqa Y, Yanada S, Sharman P, Ochi M, J Biomed Mater Res A 2005 75 23 30 16049928 (Pubitemid 41298184)
14. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Kanaya A, Deie M, Adachi N, Nishimori M, Yanada S, Ochi M, Arthroscopy 2007 23 610 617 10.1016/j.arthro. 2007.01.013 17560475 (Pubitemid 46873895)
15. Mesenchymal stem cell therapy in joint disease. Barry FP, Novartis Found Symp 2003 249 86 96 12708651
16. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: a case study. Centeno CJ, Kisiday J, Freeman M, Schultz JR, Pain Physician 2006 9 253 256 16886034 (Pubitemid 44227398)
17. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D, Med Hypotheses 2008 71 900 908 10.1016/j.mehy.2008.06.042 18786777
18. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Giannini S, Buda R, Cavallo M, Ruffilli A, Cenacchi A, Cavallo C, Vannini F, Injury 2010 41 1196 1203 10.1016/j.injury.2010.09.028 20934692
19. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pak J, Pain Physician 2012 15 75 85 22270740
20. A novel biological approach to treat chondromalacia patellae. Pak J, Lee JH, Lee SH, PLoS One 2013 8 64569 10.1371/journal.pone.0064569 23700485
21. Clinical study of the efficiency of combined cell transplant on the basis of multipotent mesenchymal stromal adipose tissue cells in patients with pronounced deficit of the maxillary and mandibulary bone tissue. Kulakov AA, Goldshtein DV, Grigoryan AS, Rzhaninova AA, Alekseeva IS, Arutyunyan IV, Volkov AV, Bull Exp Biol Med 2008 146 522 525 10.1007/s10517-009-0322-8 19489333
22. Novel maxillary reconstruction with ectopic bone formationby GMP adipose stem cells. Mesimäki K, Lindroos B, Törnwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suuronen R, Int J Oral Maxillofac Surg 2009 38 201 209 10.1016/j.ijom.2009.01.001 19168327
23. Bilateral orbitozygomatic reconstruction with tissue-engineered bone. Taylor JA, J Craniofac Surg 2010 21 1612 1614 10.1097/SCS.0b013e3181edc829 20856057
24. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone marrow-stromal cells. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M, Osteoarthr Cartil 2007 15 226 231 10.1016/j.joca.2006.08.008 17002893 (Pubitemid 46132105)
25. Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Slynarski K, Deszczynski J, Karpinski J, Transplant Proc 2006 38 318 319 10.1016/j.transproceed.2005.12.075 16504736
26. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M, Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K, Ohgushi H, J Tissue Eng Regen Med 2011 5 146 150 10.1002/term.299 20603892
27. Mesenchymal stem cell. Caplan AI, J Orthop Res 1991 9 641 650 10.1002/jor.1100090504 1870029
28. Human adipose tissue is a source of multipotent stem cells. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH, Mol Biol Cell 2002 13 4279 4295 10.1091/mbc.E02-02-0105 12475952 (Pubitemid 35471185)
29. Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Martineau I, Lacoste E, Gagnon G, Biomaterials 2004 25 4489 4502 10.1016/j.biomaterials.2003.11.013 15046940 (Pubitemid 38388609)
30. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ, J Cell Physiol 2005 205 228 236 10.1002/jcp.20391 15887229 (Pubitemid 41428905)
31. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, Del Fante C, Novara F, de Silvestri A, Amendola G, Zuffardi O, Maccario R, Locatelli F, J Cell Physiol 2007 211 121 130 10.1002/jcp.20911 17187344 (Pubitemid 46363901)
32. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Müller I, Kordowich S, Holzwarth C, Spa-no C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M, Cytotherapy 2006 8 437 444 10.1080/14653240600920782 17050248 (Pubitemid 44596996)
33. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D, Transfusion 2007 47 1436 1446 10.1111/j.1537-2995.2007.01220.x 17655588 (Pubitemid 47101060)
34. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W, Curr Stem Cell Res Ther 2010 5 81 93 10.2174/157488810790442796 19951252
35. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S, Stem Cells 2006 24 1095 1103 10.1634/stemcells.2005-0403 16282438 (Pubitemid 44464742)
36. Chromosome variability of human multipotent mesenchymal stromal cells. Bochkov NP, Voronina ES, Kosyakova NV, Liehr T, Rzhaninova AA, Katosova LD, Platonova VI, Gol'dshtein DV, Bull Exp Biol Med 2007 143 122 126 10.1007/s10517-007-0031-0 18019028 (Pubitemid 46784889)
37. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, Dufour J, Bunnell BA, Cancer Res 2008 68 4229 4238 10.1158/0008-5472.CAN-07-5272 18519682
38. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montaqna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F, Cancer Res 2007 67 9142 9149 10.1158/0008-5472.CAN-06-4690 17909019 (Pubitemid 47535900)
39. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T, J Cell Physiol 2005 205 194 201 10.1002/jcp.20376 15880640 (Pubitemid 41428901)
40. Cardiovascular disease: potential impact of stem cell therapy. Amrani DL, Port S, Expert Rev Cardiovasc Ther 2003 1 453 461 10.1586/14779072.1.3.453 15030272
41. Korean Food and Drug Administration, Cell therapy: Rules and Regulations, Chapter 2, Section 14 Seoul (Korea): The Organization 2009
42. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hindlimb ischemic mice via regulating inflammation in vivo. Fan W, Cheng K, Qin X, Narsinh KH, Wang S, Hu S, Wang Y, Chen Y, Wu JC, Xiong L, Cao F, Stem Cells 2013 31 203 214 10.1002/stem.1265 23081858
43. The inflammatory response to cell death. Rock KL, Kono H, Annu Rev Pathol 2008 3 99 126 10.1146/annurev.pathmechdis.3.121806.151456 18039143 (Pubitemid 351488277)
44. The painful semimembranosus syndrome. Halperin N, Axer A, Harefuah 1978 94 329 330 689519
45. Strain patterns in the patellar tendon and the implications for patellar tendinopathy. Almekinders LC, Vellema JH, PS, Knee Surg Sports Traumatol Arthrosc 2002 10 2 5 10.1007/s001670100224 11819013
46. Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, Murakami T, Kobayashi E, Stem Cells 2009 27 878 887 10.1634/stemcells.2008-0616 19350690